# Filing Detail

Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-13-000029
Filing Date
2013-01-04
Accepted
2013-01-04 16:28:26
Documents
137
Period of Report
2012-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDED CURRENT REPORT | f8k122812a1_cactusventures.htm | 8-K/A | 740967
2 | REGISTRATION RIGHTS AGREEMENT, BY AND AMONG ACTINIUM PHARMACEUTICALS, INC., GENE | f8k122812a1ex10i_cactus.htm | EX-10.1 | 298629
3 | AMENDMENT NO. 1 TO JUNE 30, 2000 REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER | f8k122812a1ex10ii_cactus.htm | EX-10.2 | 44480
4 | FIRST AMENDED AND RESTATED STOCKHOLDERS AGREEMENT, BY AND AMONG ACTINIUM PHARMAC | f8k122812a1ex10iii_cactus.htm | EX-10.3 | 623035
5 | SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT, BY AND AMONG ACTINIUM PHA | f8k122812a1ex10iv_cactus.htm | EX-10.4 | 236020
6 | PLACEMENT AGENT ENGAGEMENT AGREEMENT, BY AND BETWEEN LAIDLAW & COMPANY (UK) LTD. | f8k122812a1ex10v_cactus.htm | EX-10.5 | 275976
7 | EMPLOYMENT AGREEMENT, DATED JANUARY 2, 2006, BETWEEN ACTINIUM PHARMACEUTICALS, | f8k122812a1ex10viii_cactus.htm | EX-10.8 | 69239
8 | LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN SLOAN-KETTERING INS | f8k122812a1ex10ix_cactus.htm | EX-10.9 | 38387
9 | PHASE I/II STUDY ON THE SAFETY AND EFFICIENCY OF 225ACAC-HUM195 IN PATIENTS WITH | f8k122812a1ex10x_cactus.htm | EX-10.10 | 881846
10 | PRODUCT DEVELOPMENT AND PATENT LICENSE AGREEMENT, DATED FEBRUARY 27, 2003, BY AN | f8k122812a1ex10xi_cactus.htm | EX-10.11 | 24440
11 | CLINICAL TRIAL AGREEMENT, DATED JULY 19, 2012, BY AND BETWEEN FRED HUTCHINSON CA | f8k122812a1ex10xii_cactus.htm | EX-10.12 | 187275
12 | EMPLOYMENT LETTER BETWEEN JACK V. TALLEY AND ACTINIUM PHARMACEUTICALS, INC., EFF | f8k122812a1ex10xiii_cactus.htm | EX-10.13 | 33994
13 | EMPLOYMENT LETTER BETWEEN ENZA GUAGENTI AND ACTINIUM PHARMACEUTICALS, INC., EFFE | f8k122812a1ex10xiv_cactus.htm | EX-10.14 | 42843
14 | CLINICAL TRIAL AGREEMENT, DATED JANUARY 18, 2001, BETWEEN ACTINIUM PHARMACEUTICA | f8k122812a1ex10xv_cactus.htm | EX-10.15 | 9730
15 | CLINICAL TRIAL AGREEMENT WITH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, DA | f8k122812a1ex10xvi_cactus.htm | EX-10.16 | 170348
16 | CLINICAL TRIAL AGREEMENT, DATED MARCH 27, 2012, WITH MEMORIAL SLOAN-KETTERING CA | f8k122812a1ex10xvii_cactus.htm | EX-10.17 | 117749
17 | CLINICAL TRIAL AGREEMENT, DATED SEPTEMBER 22, 2012, WITH JOHNS HOPKINS UNIVERSIT | f8k122812a1ex10xviii_cactus.htm | EX-10.18 | 199334
18 | LICENSE AGREEMENT, DATED JUNE 14, 2012, FOR BC8 ANTIBODY WITH FRED HUTCHINSON CA | f8k122812a1ex10xix_cactus.htm | EX-10.19 | 187152
19 | 2012 UNIT INVESTOR RIGHTS AGREEMENT, DATED DECEMBER 19, 2012, BY AND AMONG ACTIN | f8k122812a1ex10xx_cactus.htm | EX-10.20 | 132144
20 | PROJECT AGREEMENT, DATED SEPTEMBER 30, 2011, BETWEEN ACTINIUM PHARMACEUTICALS, I | f8k122812a1ex10xxi_cactus.htm | EX-10.21 | 555785
21 | PROPOSAL, DATED MARCH 30, 2007, WITH ISOTHERAPEUTICS GROUP, LLC. | f8k122812a1ex10xxii_cactus.htm | EX-10.22 | 128782
22 | CLINICAL TRIAL AGREEMENT WITH THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER, DATE | f8k122812a1ex10xxiii_cactus.htm | EX-10.23 | 204124
23 | AMENDMENT NO. 1 TO RESEARCH AGREEMENT, DATED NOVEMBER 7, 2012, BETWEEN ACTINIUM | f8k122812a1ex10xxiv_cactus.htm | EX-10.24 | 20364
24 | LETTER AGREEMENT, DATED JUNE 19, 2011, BETWEEN ACTINIUM PHARMACEUTICALS, INC. AN | f8k122812a1ex10xxv_cactus.htm | EX-10.25 | 12577
25 | LETTER AGREEMENT, DATED APRIL 9, 2010, BETWEEN ACTINIUM PHARMACEUTICALS, INC. AN | f8k122812a1ex10xxvi_cactus.htm | EX-10.26 | 30604
26 | LETTER AGREEMENT, DATED JULY __, 2010, BETWEEN ACTINIUM PHARMACEUTICALS, INC. AN | f8k122812a1ex10xxvii_cactus.htm | EX-10.27 | 41533
27 | CLINICAL TRIAL AGREEMENT, DATED APRIL 12, 2006, WITH SLOAN-KETTERING INSTITUTE F | f8k122812a1ex10xxviii_cactus.htm | EX-10.28 | 122887
28 | LETTER AGREEMENT, DATED __, 2011, BETWEEN ACTINIUM PHARMACEUTICALS, INC. AND ACT | f8k122812a1ex10xxix_cactus.htm | EX-10.29 | 10308
29 |  | f8k122812a1ex99iii_cactus.htm | EX-99.3 | 292635
30 |  | ex10ii01.jpg | GRAPHIC | 2844
31 |  | ex10ii02.jpg | GRAPHIC | 59969
32 |  | ex10ix_1.jpg | GRAPHIC | 15525
33 |  | ex10ix_2.jpg | GRAPHIC | 50805
34 |  | ex10ix_3.jpg | GRAPHIC | 55580
35 |  | ex10ix_4.jpg | GRAPHIC | 52120
36 |  | ex10ix_5.jpg | GRAPHIC | 22754
37 |  | ex10ix_6.jpg | GRAPHIC | 92114
38 |  | ex10ix_7.jpg | GRAPHIC | 93680
39 |  | ex10ix_8.jpg | GRAPHIC | 109706
40 |  | ex10ix_9.jpg | GRAPHIC | 71801
41 |  | ex10ix_10.jpg | GRAPHIC | 91097
42 |  | ex10ix_11.jpg | GRAPHIC | 92535
43 |  | ex10ix_12.jpg | GRAPHIC | 63333
44 |  | ex10ix_13.jpg | GRAPHIC | 60955
45 |  | ex10ix_14.jpg | GRAPHIC | 72188
46 |  | ex10ix_15.jpg | GRAPHIC | 83988
47 |  | ex10ix_16.jpg | GRAPHIC | 88611
48 |  | ex10ix_17.jpg | GRAPHIC | 90799
49 |  | ex10ix_18.jpg | GRAPHIC | 80225
50 |  | ex10ix_19.jpg | GRAPHIC | 88246
51 |  | ex10ix_20.jpg | GRAPHIC | 86602
52 |  | ex10ix_21.jpg | GRAPHIC | 71442
53 |  | ex10ix_22.jpg | GRAPHIC | 53656
54 |  | ex10ix_23.jpg | GRAPHIC | 28963
55 |  | ex10ix_24.jpg | GRAPHIC | 85585
56 |  | ex10ix_25.jpg | GRAPHIC | 65818
57 |  | ex10ix_26.jpg | GRAPHIC | 84806
58 |  | ex10ix_27.jpg | GRAPHIC | 90752
59 |  | ex10ix_28.jpg | GRAPHIC | 28591
60 |  | ex10ix_29.jpg | GRAPHIC | 90666
61 |  | ex10ix_30.jpg | GRAPHIC | 53216
62 |  | ex10ix_31.jpg | GRAPHIC | 101454
63 |  | ex10ix_32.jpg | GRAPHIC | 68978
64 |  | ex10ix_33.jpg | GRAPHIC | 94113
65 |  | ex10ix_34.jpg | GRAPHIC | 46844
66 |  | ex10ix_35.jpg | GRAPHIC | 26695
67 |  | ex10ix_36.jpg | GRAPHIC | 45363
68 |  | ex10ix_37.jpg | GRAPHIC | 12994
69 |  | ex10x01.jpg | GRAPHIC | 36942
70 |  | ex10x02.jpg | GRAPHIC | 36699
71 |  | ex10x03.jpg | GRAPHIC | 15159
72 |  | ex10x04.jpg | GRAPHIC | 8351
73 |  | ex10xi_1.jpg | GRAPHIC | 83036
74 |  | ex10xi_2.jpg | GRAPHIC | 102473
75 |  | ex10xi_3.jpg | GRAPHIC | 101721
76 |  | ex10xi_4.jpg | GRAPHIC | 104454
77 |  | ex10xi_5.jpg | GRAPHIC | 93358
78 |  | ex10xi_6.jpg | GRAPHIC | 103138
79 |  | ex10xi_7.jpg | GRAPHIC | 97588
80 |  | ex10xi_8.jpg | GRAPHIC | 109656
81 |  | ex10xi_9.jpg | GRAPHIC | 93385
82 |  | ex10xi_10.jpg | GRAPHIC | 115107
83 |  | ex10xi_11.jpg | GRAPHIC | 112622
84 |  | ex10xi_12.jpg | GRAPHIC | 122412
85 |  | ex10xi_13.jpg | GRAPHIC | 119128
86 |  | ex10xi_14.jpg | GRAPHIC | 94541
87 |  | ex10xi_15.jpg | GRAPHIC | 106633
88 |  | ex10xi_16.jpg | GRAPHIC | 114639
89 |  | ex10xi_17.jpg | GRAPHIC | 76855
90 |  | ex10xi_18.jpg | GRAPHIC | 101900
91 |  | ex10xi_19.jpg | GRAPHIC | 50268
92 |  | ex10xi_20.jpg | GRAPHIC | 16302
93 |  | ex10xi_21.jpg | GRAPHIC | 58366
94 |  | ex10xi_22.jpg | GRAPHIC | 56096
95 |  | ex10xi_23.jpg | GRAPHIC | 25815
96 |  | ex10xi_24.jpg | GRAPHIC | 33051
97 |  | ex10xi_25.jpg | GRAPHIC | 39689
98 |  | ex10xi_26.jpg | GRAPHIC | 27383
99 |  | ex10xi_27.jpg | GRAPHIC | 22748
100 |  | ex10xi_28.jpg | GRAPHIC | 23878
101 |  | ex10xii01.jpg | GRAPHIC | 197466
102 |  | ex10xii02.jpg | GRAPHIC | 11444
103 |  | ex10xiii.jpg | GRAPHIC | 38861
104 |  | ex10xiv.jpg | GRAPHIC | 28156
105 |  | ex10xv_1.jpg | GRAPHIC | 84066
106 |  | ex10xv_2.jpg | GRAPHIC | 90924
107 |  | ex10xv_3.jpg | GRAPHIC | 92860
108 |  | ex10xv_4.jpg | GRAPHIC | 97303
109 |  | ex10xv_5.jpg | GRAPHIC | 80021
110 |  | ex10xv_6.jpg | GRAPHIC | 74261
111 |  | ex10xv_7.jpg | GRAPHIC | 83343
112 |  | ex10xv_8.jpg | GRAPHIC | 96194
113 |  | ex10xv_9.jpg | GRAPHIC | 99752
114 |  | ex10xv_10.jpg | GRAPHIC | 71567
115 |  | ex10xv_11.jpg | GRAPHIC | 32665
116 |  | ex10xvi01.jpg | GRAPHIC | 115663
117 |  | ex10xvi02.jpg | GRAPHIC | 239967
118 |  | ex10xvi03.jpg | GRAPHIC | 25231
119 |  | ex10xvi04.jpg | GRAPHIC | 85190
120 |  | ex10xvii01.jpg | GRAPHIC | 159315
121 |  | ex10xvii02.jpg | GRAPHIC | 23361
122 |  | ex10xviii01.jpg | GRAPHIC | 223335
123 |  | ex10xviii02.jpg | GRAPHIC | 32669
124 |  | ex10xviii03.jpg | GRAPHIC | 110535
125 |  | ex10xxii_1.jpg | GRAPHIC | 23794
126 |  | ex10xxii_2.jpg | GRAPHIC | 134198
127 |  | ex10xxii_3.jpg | GRAPHIC | 13241
128 |  | ex10xxii_4.jpg | GRAPHIC | 48161
129 |  | ex10xxiii_1.jpg | GRAPHIC | 81311
130 |  | ex10xxiii_2.jpg | GRAPHIC | 82339
131 |  | ex10xxiii_3.jpg | GRAPHIC | 32213
132 |  | ex10xxiv_01.jpg | GRAPHIC | 201162
133 |  | ex10xxv_logo.jpg | GRAPHIC | 5239
134 |  | ex10xxvii.jpg | GRAPHIC | 4248
135 |  | ex10xxi_logo.jpg | GRAPHIC | 10395
136 |  | ex10xxi_sign.jpg | GRAPHIC | 4500
137 |  | ex10xxi_sign01.jpg | GRAPHIC | 3850
| Complete submission text file | 0001213900-13-000029.txt |  | 16381110

Mailing Address 123 W NYE LANE, STE 129 CARSON CITY NV 89706
Business Address 123 W NYE LANE, STE 129 CARSON CITY NV 89706 831-770-0217
Cactus Ventures, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-52446 | Film No.: 13512117
SIC: 6770 Blank Checks